This session will explore a forward-looking vision for Pharma and Biotech manufacturing that transcends traditional Manufacturing Execution Systems (MES). As MES evolves, manufacturers are adopting adaptable, modular solutions that ensure interoperability, flexibility, and easy configuration. By prioritizing people and processes, companies can optimize manufacturing efficiency while enhancing data integrity and compliance, leading to significant operational improvements. In this session you will learn more about how to:

Manage the production process and quality in real time from order to batch release in one browser-based user interface visualizing real-time and historical data.

• Digitize all direct batch execution (EBR) and execution related activities (Logbooks and Digital Procedures) to eliminate paper or unstructured electronic records where data is trapped.
• Leverage out of the box and configurable functionality on a no-code platform.
• Analyze and report on operational data in one place for a single source of the truth.
• Achieve measurable results in cost reduction, risk mitigation, and revenue opportunities.

• What are the main challenges manufacturers face when trying to unify real-time production and quality management into one platform?
• How can the elimination of paper-based records and unstructured data enhance compliance and operational efficiency?
• What role do no-code platforms play in enabling adaptability and customization in Pharma manufacturing?
• How can organizations ensure seamless data analysis and reporting to establish a single source of truth?
• What measurable business benefits, such as cost reduction and risk mitigation, have been realized through unified manufacturing platforms?